Showing 41 - 60 results of 447 for search '"radiation therapy"', query time: 0.09s Refine Results
  1. 41
  2. 42

    A dosimetric comparison of non-coplanar volumetric modulated arc therapy and non-coplanar fixed field intensity modulated radiation therapy in hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for brain metastases by Huaqu Zeng, MinZhi Zhong, Zongyou Chen, Shukui Tang, Zunbei Wen

    Published 2025-01-01
    “…ObjectiveThe aim of this study was to investigate the dosimetric differences between non-coplanar volumetric modulated arc therapy (VMAT) and non-coplanar fixed-field intensity-modulated radiotherapy (IMRT) in hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost (HA-WBRT+SIB) for brain metastases using the Monaco treatment planning system (TPS).MethodA total of 22 patients with brain metastases were retrospectively enrolled. …”
    Get full text
    Article
  3. 43
  4. 44
  5. 45

    Intensity-modulated radiation therapy for early-stage breast cancer: a systematic review and meta-analysis by Samir Abdallah Hanna, Bruna Salani Mota, Fabio Ynoe de Moraes, Gustavo Nader Marta, Heloísa de Andrade Carvalho, Rachel Riera

    Published 2024-12-01
    “…ABSTRACT BACKGROUND: Radiation therapy (RT) is a standard treatment for non-metastatic breast cancer and is associated with acute and late toxicities. …”
    Get full text
    Article
  6. 46
  7. 47
  8. 48

    Early Invasive Cancer and Partial Intraoperative Electron Radiation Therapy of the Breast: Experience of the Jules Bordet Institute by C. Philippson, S. Simon, C. Vandekerkhove, D. Hertens, I. Veys, D. Noterman, F. De Neubourg, D. Larsimont, P. Bourgeois, P. Van Houtte, J. M. Nogaret

    Published 2014-01-01
    “…The aim of this prospective phase II study is to evaluate the treatment of early-stage breast cancer (T1 N0) with intraoperative electron radiation therapy (IOERT) in terms of local control, early complications, and cosmesis. …”
    Get full text
    Article
  9. 49
  10. 50
  11. 51

    Diffuse panbronchiolitis as a rare complication of thymectomy and radiation therapy in a patient with thymoma: a case report by Ye Lu, Qi Qi, Dan Qu, Yu Chen

    Published 2025-01-01
    “…Both thymectomy and radiation therapy can contribute to the development of DPB. …”
    Get full text
    Article
  12. 52

    External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study by Caroline M. van der Starre, Chris H. Bangma, Maarten J. Bijlsma, Alfons C.M. van den Bergh, Lambertus A.L.M. Kiemeney, Wietske Kievit, Kees Vos, Diederik M. Somford, Sally M. Wildeman, Katja K.H. Aben, Igle J. de Jong, Floris J. Pos, Berdine L. Heesterman

    Published 2025-01-01
    “…The study primarily aims to evaluate and compare the impact of treatment with robot-assisted radical prostatectomy (RP) versus external beam radiation therapy (EBRT) with androgen deprivation therapy (ADT) for men with high-risk, non-metastatic PCa regarding health-related quality of life (HRQoL) and functional outcomes. …”
    Get full text
    Article
  13. 53

    Selective Internal Radiation Therapy for Gastrointestinal Neuroendocrine Tumour Liver Metastases: A New and Effective Modality for Treatment by Harshal Rajekar, Kashan Bogammana, Richard S. Stubbs

    Published 2011-01-01
    “…Selective Internal Radiation Therapy (SIRT) is becoming recognized as a new modality for selectively treating non-resectable liver tumours. …”
    Get full text
    Article
  14. 54

    18F-Fluorothymidine-Pet Imaging of Glioblastoma Multiforme: Effects of Radiation Therapy on Radiotracer Uptake and Molecular Biomarker Patterns by Sanjay Chandrasekaran, Andrew Hollander, Xiangsheng Xu, Joseph L. Benci, James J. Davis, Jay F. Dorsey, Gary Kao

    Published 2013-01-01
    “…These studies were undertaken to investigate the effectiveness of 18F-FLT-PET in a GBM mouse model, especially after radiation therapy (RT), and its correlation with useful biomarkers, including proliferation and DNA damage. …”
    Get full text
    Article
  15. 55
  16. 56
  17. 57
  18. 58

    Risk of Subclinical Hypothyroidism in Breast Cancer Patients Treated With CT-Guided Radiation Therapy: A Prospective Observational Study by Amdisen L, Brink C, Lorenzen EL, Roenlev JD, Ewertz M, Cronin-Fenton D

    Published 2025-01-01
    “…Lau Amdisen,1 Carsten Brink,2,3 Ebbe Laugaard Lorenzen,2,3 Jeanette Dupont Roenlev,4 Marianne Ewertz,2 Deirdre Cronin-Fenton1 1Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark; 2Department of Clinical Research, University of Southern Denmark, Odense, Denmark; 3Laboratory of Radiation Physics, Department of Oncology, Odense University Hospital, Odense, Denmark; 4Department of Oncology, Odense University Hospital, Odense, DenmarkCorrespondence: Lau Amdisen, Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Olof Palmes Allé 43-45, Aarhus N, 8200, Denmark, Tel +45 8716 8229, Email amdisen@clin.au.dkPurpose: The thyroid gland is an organ at risk in breast cancer survivors who receive radiation therapy to the supraclavicular lymph nodes. We investigated the effect of radiation dose to the thyroid gland on the incidence of hypothyroidism in early-stage breast cancer patients treated with CT-guided radiation therapy.Patients and Methods: We recruited women aged ≤ 75 years diagnosed with breast cancer from March 2016 through August 2017 at Odense University Hospital, Denmark. …”
    Get full text
    Article
  19. 59

    Maintenance of patient-reported health-related quality of life post neoadjuvant relugolix prior to the initiation of prostate radiation therapy by Min Jung Koh, Min Ji Koh, Jessica Y. Hsueh, Lindsey Gallagher, Malika Danner, Alan Zwart, Marilyn Ayoob, Deepak Kumar, Michael Carrasquilla, Paul Leger, Nancy A. Dawson, Simeng Suy, Sean P. Collins

    Published 2025-01-01
    “…No statistically or clinically significant changes were observed in any of the five individual items.ConclusionThe use of neoadjuvant relugolix prior to prostate radiation therapy had no clinically significant impact on patient-reported health-related quality of life. …”
    Get full text
    Article
  20. 60